Literature DB >> 28969137

Haemostatic Profile of Patients with Chronic Liver Disease- its Correlation with Severity and Outcome.

Varnika Rai1, Neeraj Dhameja2, Sandip Kumar2, Jyoti Shukla3, Rajeev Singh4, Vinod Kumar Dixit5.   

Abstract

INTRODUCTION: The liver plays an important role in the haemostatic system as it synthesizes the majority of coagulation factors and fibrinolytic proteins. AIM: The present study was planned to determine the range of haemostatic defects in patients of chronic liver diseases.
MATERIALS AND METHODS: Test performed included Prothrombin Time (PT), activated Partial Thromboplastin Time (aPTT), Thrombin Time (TT), Fibrinogen, Protein C, D Dimer and platelet count. Comparisons between groups frequencies and groups means were made using Chi-square test and Student's t-test, respectively.
RESULTS: In cirrhosis group PT, aPTT, TT and D Dimer level were significantly increased compared to Chronic Hepatitis (CH) and control group (p<0.001 for all comparisons). Serum fibrinogen, Protein C and platelet count were significantly reduced in cirrhosis patients compared to CH and control group. (p<0.001 for all comparisons). All studied coagulation parameters were within normal limit in CH group. However, statistically significant difference was found in protein C and mean platelet count in CH group compared to control (p=0.03 and p<0.001 respectively). No evidence of bleeding or thrombosis was present in study group.
CONCLUSION: In cirrhosis patients severe derangement in both anti and procoagulant factors occurs. Haemostatic profile in chronic hepatitis patient remains within normal limits.

Entities:  

Keywords:  Chronic hepatitis; Cirrhosis; D Dimer; Fibrinogen; Protein C

Year:  2017        PMID: 28969137      PMCID: PMC5620777          DOI: 10.7860/JCDR/2017/24975.10451

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

Review 1.  Haemostatic abnormalities in patients with liver disease.

Authors:  Ton Lisman; Frank W G Leebeek; Philip G de Groot
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

Review 2.  Splenomegaly, hypersplenism and coagulation abnormalities in liver disease.

Authors:  P A McCormick; K M Murphy
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  2000-12

3.  Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?

Authors:  Abeer K Al Ghumlas; Abdel Galil M Abdel Gader; Faleh Z Al Faleh
Journal:  Blood Coagul Fibrinolysis       Date:  2005-07       Impact factor: 1.276

4.  Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

Authors:  G V Papatheodoridis; E Papakonstantinou; E Andrioti; E Cholongitas; K Petraki; I Kontopoulou; S J Hadziyannis
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

5.  Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.

Authors:  Patrick G Northup; Matthew M McMahon; A Parker Ruhl; Scott E Altschuler; Agata Volk-Bednarz; Stephen H Caldwell; Carl L Berg
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

6.  Natural anticoagulants can be useful predictors of severity in chronic liver disease.

Authors:  Ayman A Abdo; Faisal M Sanai; Nahla Azzam; Khalid Al Sawat; Manal Al Dukhayil; Abeer Al Ghumlas; Ahmad Hersi; Abdel Galil Abdel Gader
Journal:  Blood Coagul Fibrinolysis       Date:  2010-03       Impact factor: 1.276

Review 7.  Coagulation abnormalities in liver disease.

Authors:  E F Mammen
Journal:  Hematol Oncol Clin North Am       Date:  1992-12       Impact factor: 3.722

Review 8.  Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.

Authors:  A Tripodi; S H Caldwell; M Hoffman; J F Trotter; A J Sanyal
Journal:  Aliment Pharmacol Ther       Date:  2007-07-15       Impact factor: 8.171

Review 9.  Thrombocytopenia associated with chronic liver disease.

Authors:  Nezam Afdhal; John McHutchison; Robert Brown; Ira Jacobson; Michael Manns; Fred Poordad; Babette Weksler; Rafael Esteban
Journal:  J Hepatol       Date:  2008-03-31       Impact factor: 25.083

10.  The coagulopathy of liver disease: does vitamin K help?

Authors:  Maha F Saja; Ayman A Abdo; Faisal M Sanai; Shaffi A Shaikh; Abdel Galil M Abdel Gader
Journal:  Blood Coagul Fibrinolysis       Date:  2013-01       Impact factor: 1.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.